Insider buying · SEC Form 4

Insider Buying — Sep 29, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

5insider buys
$34.4Mbought in total
5companies
2by CEOs, CFOs and other chiefs
GPIlargest: $31.5M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
GPIGroup 1 Automotive IncConifer Management, L.L.C.10% Owner$31.5M126,288$249.62AddedSep 28, 2026
Form 4 ↗
13 transactions across 9/24–9/25 at weighted avg ~$249.98/share; now $242.23 (−3.1% since buy). Conifer Management simultaneously adding board representation (Benjamin Hart joining Nov 1). Consistent cluster buyer all September.
KBDCKayne Anderson BDC IncJames L. RoboDirector$1.37M105,000$13.05AddedSep 28, 2026
Form 4 ↗
Bought indirectly via Ventus Capital, LLC (Robo is manager). 105,000 shares at $13.046 on 9/24; now $13.03 (−0.1% since buy). Part of a ~$5.2M September buying campaign near 52-week lows. Robo is Chairman of the Board.
INBXInhibrx Biosciences IncMark LappeCEO$999K10,000$99.88AddedSep 28, 2026
Form 4 ↗
Two tranches on 9/25: 5,500 shares at $99.16 and 4,500 shares at $100.76 (avg ~$99.88); now $101.71 (+1.8% since buy). Founder-CEO has purchased ~$3.6M in INBX this month. Serial buyer throughout 2026.
LILAPLiberty Latin America LtdJohn C. Malone10% Owner$273K13,362$20.44AddedSep 28, 2026
Form 4 ↗
13,362 Series A Preference Shares at $20.44 on 9/25; now $20.40 (−0.2% since buy). Liquidation value $25/share — buying at ~18% discount. Malone has purchased $1M+ in LILAP this month alone. Consistent accumulation pattern.
DMRADamora Therapeutics IncJennifer JarrettDirector, President and CEO$253K12,500$20.23AddedSep 28, 2026
Form 4 ↗
12,500 shares at ~$20.23 on 9/25; now $20.75 (+2.6% since buy). CEO buy at a small clinical-stage company — skin-in-the-game signal.

AIThe day in insider buying

SEC Form 4 Insider Scan — September 29, 2026

Scanned the last 24 hours of EDGAR Form 4 filings. 5 qualifying buys (≥ $250K, transaction type P) totalling $34.4M.

Headline filings

  • GPI — Conifer Management, L.L.C. (10% Owner) bought 126,288 shares ≈ $31.5M at $249.98 avg; now $242.23 (−3.1% since buy). (filing)
  • KBDC — James L. Robo (Director, via Ventus Capital LLC) bought 105,000 shares ≈ $1.4M at $13.05 avg; now $13.03 (−0.1% since buy). (filing)
  • INBX — Mark Lappe (CEO & Founder) bought 10,000 shares ≈ $999K at $99.88 avg; now $101.71 (+1.8% since buy). (filing)
  • LILAP — John C. Malone (10% Owner) bought 13,362 Series A Preference Shares ≈ $273K at $20.44; now $20.40 (−0.2% since buy). (filing)
  • DMRA — Jennifer Jarrett (Director, President & CEO) bought 12,500 shares ≈ $253K at $20.23; now $20.75 (+2.6% since buy). (filing)

Notes

GPI dominates the session. Conifer Management executed $31.5M across 13 transactions on Sept 24–25 — their largest weekly buy tranche since early September. The activist fund is simultaneously installing a board member (Benjamin Hart from Conifer's Acacia funds, effective Nov 1) as they accumulate. Stock is -3.1% below their avg cost basis, giving the fund a near-term paper loss but suggesting continued conviction at these levels.

KBDC director James Robo has invested ~$5.2M in the BDC during September alone, buying near 52-week lows via Ventus Capital. His cluster buying signals confidence in Kayne Anderson's portfolio quality and dividend sustainability. Stock essentially flat vs. buy price.

INBX founder-CEO Mark Lappe has now purchased ~$3.6M worth of Inhibrx Biosciences shares in September alone — strong serial conviction from the top. Stock is +1.8% above this latest tranche's cost.

Sector themes: Automotive dealership (GPI) and BDC/financials (KBDC) are the two biggest dollars; biotech (INBX, DMRA) rounds out the list. John Malone (LILAP) continues his methodical accumulation of Liberty Latin America preference shares at a discount to $25 liquidation value.

Most-bought stocks, last 30 days

  • RSG $279M · 2 buys, 2 insidersRepublic Services, Inc.
  • LEN $212M · 1 buyLennar Corp
  • GPI $112M · 4 buys, 2 insidersGroup 1 Automotive Inc
  • GME $94.3M · 6 buys, 2 insidersGameStop Corp
  • GRAB $60.6M · 3 buys, 3 insidersGrab Holdings Ltd
  • UBER $30.6M · 4 buys, 2 insidersUber Technologies, Inc.
  • QVCG $26.0M · 1 buyQVC Group, Inc.
  • ALMS $21.4M · 2 buysAlumis Inc.
  • CRBG $12.0M · 2 buysCorebridge Financial Inc
  • KBDC $8.09M · 3 buysKayne Anderson BDC Inc
  • ENHA $6.99M · 1 buyEnhanced Group Inc
  • ADC $6.69M · 6 buys, 3 insidersAgree Realty Corp
  • NFE $6.69M · 2 buys, 2 insidersNew Fortress Energy Inc
  • INBX $5.00M · 5 buys, 4 insidersInhibrx Biosciences Inc
  • NYAX $4.61M · 1 buyNayax Ltd.
  • BORR $4.30M · 1 buyBorr Drilling Ltd
  • PETZ $3.56M · 1 buyTDH Holdings Inc.
  • BBD $3.44M · 2 buys, 2 insidersBanco Bradesco SA
  • AMR $3.40M · 2 buysAlpha Metallurgical Resources, Inc.
  • SUJA $3.13M · 1 buySuja Life, Inc.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.